The metabolism of leukotriene B4 dihydroxy-6-cis-8,10-trans-14-cis-eic
osatetraenoic acid) by isolated guinea pig eosinophils was investigate
d. Incubation of guinea pig eosinophils with [H-3]-leukotriene B4 resu
lted in the rapid conversion of leukotriene B4 to several more polar m
etabolites. Two of these metabolites were identified by ultraviolet sp
ectroscopy and gas chromatography-mass spectrometry as the omega oxida
tion products (S),12(R),20-trihydroxy-6,8,10,14-eicosatetraenoic acid
(20-hydroxy-leukotriene B4) and 5(S),12(R), 19-trihydroxy-6,8,10,14-ei
cosatetraenoic acid (19-hydroxy-leukotriene B4). Two novel metabolites
, 5(S),12(R),18,19-tetrahydroxy-6,8,10,14 eicosatetraenoic acid (18,19
-dihydroxy-leukotriene B4) and -1,18-dicarboxylic-6,8,10,14,16-octadec
apentaenoic acid (DELTA16,17-18-carboxy-19,20-dinor-leukotriene B4) we
re tentatively identified. The identification of these compounds indic
ates that guinea pig eosinophils are capable of metabolizing leukotrie
ne B4 by both omega and beta oxidation. This catabolic activity may pl
ay a role in modulating inflammatory reactions by removing the chemoat
tractant leukotriene B4 from inflammatory sites.